Refocus Group, Inc. (RFCS) Stock Analysis
DELISTED
What happened to Refocus Group, Inc. (RFCS) stock?
Refocus Group, Inc. (RFCS) no longer trades on public markets. The figures below are historical and are not a current quote.
- Status:
- Delisted — no longer trades
For informational purposes only. Not financial advice. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Refocus Group, Inc. (RFCS). Refocus Group, Inc. is a medical device company focused on developing treatments for human vision disorders, primarily presbyopia. Their lead product, the VisAbility Micro-Insert System, is currently undergoing clinical trials for binocular presbyopic treatment.
Last analyzed: Mar 18, 2026Refocus Group, Inc. (RFCS) Healthcare & Pipeline Overview
RFCS OTC Market Information
RFCS trades on the OTC Other market tier of OTC Markets.
- OTC Tier: OTC Other
More about this archive record
Can I still buy RFCS shares?
No. RFCS stopped trading on public markets, so the shares are not available through a broker. Anything you see quoted for RFCS elsewhere is historical data, not a live market.
Are the figures on this page current?
No. Every number here is the last value recorded before RFCS stopped trading. Nothing on this page updates, and none of it is a current quote.
Why does this page still exist?
Because people still search for what happened to Refocus Group, Inc.. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.